Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Board Appointments

8 Feb 2007 07:00

Torex Retail PLC07 February 2007 7 February 2007 Torex retail plc (the "Company") Board Appointments Torex Retail plc, a leading global retail systems provider, today provides anupdate following the announcement of management actions issued on 31 January2007. The Company announces that Mr Keith Taylor has been appointed to the main Boardwith immediate effect as Acting Chief Executive Officer. Keith Taylor has justcompleted 7 months as Turnaround Director in the NHS. His IT sector experiencehas been at Morse Plc where he initially integrated the Diagonal acquisitionbefore going on to radically change their reseller business, which remains asuccessful service-led company. He was also Chief Operating Officer at Admiralplc where he was responsible for transforming the Group into a wholly integratedbusiness before its onward sale to CMG. Mr Iain Lynam has also been appointed to the main Board with immediate effectwith specific responsibility for managing any restructuring of the businesswhich may be appropriate. The Company also confirms that it remains in dialogue with its lenders whocontinue to be supportive of the restructuring process. The Board would like to take the opportunity to thank its employees, customersand suppliers for their support during this challenging time. The Company willmake a further announcement with a full financial update as soon as possible. - Ends - Enquiries: Keith TaylorActing CEO, Torex Retail plcTel: 0870 300 6061 Ginny Pulbrook / Seb Hoyle / Lucie HollowayCitigate Dewe RogersonTel: 020 7638 9571 Additional details are set out below: Keith Wilhall Taylor (age 58)Present directorships or partnerships: Crispins Partnership Ltd Directorships or partnerships in previous five years: Meta Management ServicesLimited, Aktrion Plus Limited, QE Recruitment Limited, QE Consultancy Limited,Aktrion Group Limited, QE International Limited, Aktrion Trustees Limited,Aktrion Manufacturing Support Services Limited, Panini (Europe) ltd Details of companies entering insolvency whilst a director or within 12 monthsof resignation: Panini (Europe) Limited - creditors voluntary liquidation No unspent convictions, bankruptcy or IVAs, no receivership of assets, no publiccriticism by regulatory bodies Robert Iain Lynam (age 54) Present directorships or partnerships: Combe Bank School Educational Trust,Imago Investments Limited, Citex UK Holdings Limited, Citex ProfessionalServices Limited, Citex Group Limited, Society of Turnaround Professionals, NSMT Ventures LimitedAaronite Partners Limited Directorships or partnerships in previous five years: Hudson EngineeringServices Limited, WRM Logistics Limited, Cbora Freehold Limited, ScriptorServices Limited, Sandiford Road Limited, GHE2 (2002) Limited, Unis GroupLimited, Citex Water & Facilities Limited, Bucknall Pck Limited, GH ElectricalGroup Limited, Bucknall Austin Project Management Services Limited, Frost BevanLimited, Tapley & Edworthy Limited,Marlin Construction Management Limited, BA Realisations Limited, Bucknall AustinFerris Watson Limited, Simok Limited, Unis Limited, FBA Limited, Citex Property& Facilities Limited, Frost Bevan Holdings Limited, Frost Bevan PartnershipLimited,Bucknall Sterling Programme Management Limited, Bucknall Limited, Citex ProjectDelivery Limited, VSI Limited, Sigma Building Solutions Limited, CitexInternational Holdings Limited, Citex Group Services Limited, Details of companies entering insolvency whilst a director or within 12 monthsof resignation: GH Electrical Group Limited - receivership, GHE2 (2002) Limited- receivership, Sandiford Road Limited - liquidation, HMG (South) Limited -receivership,HMG (Clearwater) Limited - receivership, HMG (London) Limited - receivership,HMG Holdings Limited - receivership, HMG (Thames) Limited - receivership,HMG (Midlands) Limited - receivership, Avidmoor Limited - receivership, HancockSouthern Limited -receivership, Hancock Group Limited - receivership, Citex UKHoldings Limited - liquidation, Citex Professional Services Limited -liquidation, Citex Group Limited - liquidation, No unspent convictions, bankruptcy or IVAs, no receivership of assets, no publiccriticism by regulatory bodies There is nothing further to disclose in relation to their appointment pursuantto Rule 17 of the AIM Rules. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th May 201812:12 pmRNSResult of AGM
2nd May 20187:00 amRNSTRX BioSurgery GPO agreement with Premier, Inc.
27th Apr 20187:00 amRNSPosting of Annual Report and Notice of AGM
24th Apr 20187:00 amRNSDermaPure manufacturing at CellRight Facility
19th Apr 20183:29 pmRNSHolding(s) in Company
5th Apr 20187:17 amEQSHardman & Co Research: Tissue Regenix (TRX): CellRight hits the right note
26th Mar 20187:00 amRNSAnnual results for period ended 31 December 2017
16th Mar 20183:40 pmRNSPublication of Financial Results
8th Mar 20187:15 amRNSHardman & Co: Full-year 2017 - what to look for
6th Mar 20187:00 amRNSLong term distribution agreement with Arthrex, Inc
26th Feb 20187:00 amRNSNotice of Results
26th Feb 20187:00 amRNSLaunch of BioSurgery and new distributor agreement
2nd Feb 20187:00 amRNSIssue of Equity
22nd Dec 20179:30 amRNSIssue of Equity
1st Dec 20177:00 amRNSDirectorate Change
1st Dec 20177:00 amRNSIssue of Equity
2nd Nov 20177:00 amRNSAppointment of CEO
18th Oct 20177:00 amRNSDirectorate Change
11th Oct 20177:15 amRNSHardman Research: Dual revenue stream growth
28th Sep 20173:15 pmRNSUnaudited Interim Results
8th Sep 20177:00 amRNSNotice of Results
5th Sep 20173:52 pmRNSNotification Of Major Holdings
30th Aug 20175:15 pmRNSIssue of Equity
16th Aug 201712:22 pmRNSHolding(s) in Company
11th Aug 20173:45 pmRNSHolding(s) in Company
11th Aug 20173:37 pmRNSHolding(s) in Company
10th Aug 20174:30 pmRNSHolding(s) in Company
10th Aug 20172:45 pmRNSHolding(s) in Company
10th Aug 20171:10 pmRNSHardman Research: CellRight transforming US growth
10th Aug 201710:10 amRNSHolding(s) in Company
9th Aug 20173:00 pmRNSHolding(s) in Company
9th Aug 20172:30 pmRNSDirector/PDMR Shareholding
8th Aug 20171:41 pmRNSResults of General Meeting and Total Voting Rights
21st Jul 20176:00 pmRNSCirc re.CellRight Acquisition
21st Jul 20178:05 amRNSSuccessful fundraising of £40 million
20th Jul 20176:03 pmRNSProposed Acquisition and Placing
30th Jun 201712:00 pmRNSResult of AGM
2nd Jun 20177:00 amRNSAnnual results for period ended 31 December 2016
31st May 201710:46 amRNSPotential Acquisition Update
19th May 201711:35 amRNSPotential Acquisition
3rd Apr 20177:00 amRNSIssue of Equity
13th Mar 20177:10 amRNSHardman Research: Addressing woundcare in the US
1st Mar 20177:00 amRNSInnovative Technology Contract Awarded
2nd Feb 20177:00 amRNSDermaPure® added to the Federal Supply Schedule
6th Jan 20177:00 amRNSDirectorate Change
9th Dec 20167:15 amRNSHardman Research: a/c change: Not simply 11/12ths
7th Dec 20161:04 pmRNSTR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
6th Dec 20167:00 amRNSDermaPure secures GPO agreement with Premier, Inc.
28th Nov 20167:05 amRNSOrthoPureT XT update
22nd Nov 20167:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.